Related Experiment Video
Updated: Mar 8, 2026

10:46
Doppler Optical Coherence Tomography of Retinal Circulation
Published on: September 18, 2012
19.3K
[Prostaglandins and optic papilla blood flow]
1Department of Ophthalmology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China.
[Zhonghua Yan Ke Za Zhi] Chinese Journal of Ophthalmology
|February 7, 2017
Summary
Glaucoma damages optic nerve head blood flow. This review examines how prostaglandin drugs, a first-line glaucoma treatment, affect optic papilla blood flow and discusses future research needs.
Area of Science:
- Ophthalmology
- Microcirculation Research
- Pharmacology
Background:
- Glaucoma is associated with damage to peripapillary microcirculation.
- Blood flow within the optic nerve head is a critical factor in glaucoma development.
- Understanding the impact of glaucoma medications on ocular blood flow is essential.
Purpose of the Study:
- To review experimental and clinical studies on the effects of prostaglandins on optic papilla blood flow.
- To explore the mechanisms by which prostaglandins may influence blood flow in the optic nerve head.
- To highlight the need for further research into the role of increased ocular blood flow in glaucoma treatment.
Main Methods:
- Literature review of experimental and clinical studies.
- Analysis of research on prostaglandin analogs and their effects on ocular hemodynamics.
- Synthesis of findings related to optic nerve head microcirculation in glaucoma patients.
Main Results:
- Prostaglandins are a primary therapeutic class for glaucoma.
- Evidence suggests prostaglandins have the potential to modulate blood flow in the optic papilla.
- The precise mechanisms and clinical significance of these effects require additional investigation.
Conclusions:
- Prostaglandins, as a first-line glaucoma therapy, warrant attention for their effects on optic nerve head blood flow.
- Further research is necessary to elucidate the role of enhanced ocular blood flow in glaucoma management.
- Investigating the impact of prostaglandins on microcirculation may offer new insights into glaucoma pathogenesis and treatment.
Related Concept Videos
Glaucoma: Overview
1.6K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.6K
Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
Autoregulation of Blood Flow
8.5K
Autoregulation mechanisms are characterized by their inherent capacity for self-regulation without necessitating specific nervous stimulation or endocrine control. These mechanisms facilitate the adjustment of blood flow and, therefore, perfusion specific to each tissue region. This self-regulation encompasses chemical signals and myogenic controls.
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation....
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation....
8.5K
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
564
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
564

